Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-02-24
2009-11-03
McKane, Joseph K (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S253000
Reexamination Certificate
active
07612077
ABSTRACT:
The invention concerns certain crystalline solvates and hydrates of the compound of the Formula (I) which is known inter alia by way of the code number ZD1839. In particular, the invention concerns a first solvate that occurs in the presence of methanol which is designated as Form 2 ZD1839 MeOH solvate, a second solvate that occurs in the presence of dimethyl sulphoxide which is designated as Form 3 ZD1839 DMSO solvate and a trihydrate that occurs in the presence of water which is designated Form 5 ZD1839 trihydrate. The invention further concerns processes for the preparation of these solvates and the trihydrate and for their conversion back to the compound ZD1839, pharmaceutical compositions containing them and their use in the manufacture of medicaments for use the production of an anti-proliferative effect in a warm-blooded animal such as man.
REFERENCES:
patent: 5457105 (1995-10-01), Barker
patent: 5616582 (1997-04-01), Barker
patent: 5770599 (1998-06-01), Gibson
patent: 96/33980 (1996-10-01), None
patent: 96/33980 (1996-10-01), None
patent: WO-96/33980 (1996-10-01), None
patent: 01/76586 (2001-10-01), None
patent: 03/072139 (2003-09-01), None
Astrazeneca AB
Coppins Janet L
McKane Joseph K
Morgan & Lewis & Bockius, LLP
LandOfFree
Crystalline forms of the anti-cancer compound ZD1839 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of the anti-cancer compound ZD1839, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of the anti-cancer compound ZD1839 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134846